Stockscreener 앱 받기
84.53
0.60%
-0.51
시간 외 거래:
86.27
1.74
+2.06%
전일 마감가:
$85.04
열려 있는:
$85.63
하루 거래량:
14.19M
Relative Volume:
2.92
시가총액:
$262.16B
수익:
$56.53B
순이익/손실:
$8.32B
주가수익비율:
31.75
EPS:
2.6622
순현금흐름:
$8.49B
1주 성능:
-0.91%
1개월 성능:
+4.60%
6개월 성능:
+30.31%
1년 성능:
+9.96%
1일 변동 폭
$83.84
$85.88
1주일 범위
$83.84
$86.57
52주 변동 폭
$61.24
$86.57
아스트라제네카 ADR Stock (AZN) Company Profile
명칭
Astrazeneca PLC
전화
44 20 3749 5000
주소
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
AZN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZN
Astrazeneca PLC
|
84.53 | 263.67B | 56.53B | 8.32B | 8.49B | 2.6622 |
아스트라제네카 ADR Stock (AZN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-15 | 개시 | Exane BNP Paribas | Outperform |
| 2025-02-13 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-12 | 개시 | Morgan Stanley | Overweight |
| 2024-11-20 | 업그레이드 | UBS | Sell → Neutral |
| 2024-11-06 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-09-13 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-04-16 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-02-08 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2024-01-23 | 개시 | Morgan Stanley | Overweight |
| 2024-01-16 | 재개 | UBS | Sell |
| 2024-01-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-09-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-05 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-04-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2022-09-15 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | 업그레이드 | Argus | Hold → Buy |
| 2022-06-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-11 | 업그레이드 | DZ Bank | Sell → Hold |
| 2021-12-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-08-12 | 재개 | JP Morgan | Overweight |
| 2021-04-12 | 다운그레이드 | Argus | Buy → Hold |
| 2021-03-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-25 | 업그레이드 | UBS | Neutral → Buy |
| 2021-01-15 | 개시 | Deutsche Bank | Buy |
| 2020-12-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | 업그레이드 | UBS | Sell → Neutral |
| 2020-11-11 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2020-09-29 | 개시 | Berenberg | Buy |
| 2019-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-10-25 | 업그레이드 | Liberum | Hold → Buy |
| 2019-04-02 | 다운그레이드 | UBS | Neutral → Sell |
| 2019-02-05 | 개시 | Exane BNP Paribas | Outperform |
| 2019-01-25 | 업그레이드 | Shore Capital | Hold → Buy |
| 2018-12-11 | 재개 | Jefferies | Hold |
| 2018-10-09 | 개시 | Guggenheim | Buy |
| 2018-08-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-03-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-02-06 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-05 | 재확인 | Bernstein | Outperform |
| 2018-01-18 | 재확인 | Leerink Partners | Mkt Perform |
| 2017-12-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
모두보기
아스트라제네카 ADR 주식(AZN)의 최신 뉴스
US FDA Commissioner’s Involvement In AstraZeneca Pricing Deal Raises Ethical, Legal Questions - insights.citeline.com
President Trump announces deal with AstraZeneca on drug prices and tariffs - Taipei Times
Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump - MarketScreener
AstraZeneca PLC $AZN Shares Bought by Aberdeen Group plc - MarketBeat
AstraZeneca PLC $AZN Stock Holdings Lowered by US Bancorp DE - MarketBeat
AstraZeneca Signs US Drug Pricing Deal, Secures Three-year Delay to Tariffs - MarketScreener
Target Identification and Validation In Drug Discovery - Oncodaily
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts - ts2.tech
Benson Investment Management Company Inc. Takes $4.44 Million Position in AstraZeneca PLC $AZN - MarketBeat
Mengis Capital Management Inc. Grows Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Acquired by Ramirez Asset Management Inc. - MarketBeat
AstraZeneca PLC $AZN Stock Holdings Lowered by Blair William & Co. IL - MarketBeat
Callan Family Office LLC Has $3.90 Million Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
Trump announces deal with AstraZeneca to cut drug prices across US - Hindustan Times
AstraZeneca Strikes 'Most Favored Nation' Price Deal - Law360
AstraZeneca (AZN) Reaches Agreement with White House to Lower Dr - GuruFocus
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal - MarketScreener
AstraZeneca Agrees To Lower Drug Prices For Medicaid Under Trump Administration Deal - Barchart.com
AstraZeneca : announces historic agreement with US Government to lower the cost of medicines for American patients - MarketScreener
Trump Announces AstraZeneca Drug Price Cuts for Tariff Reprieve - Bloomberg.com
Trump says AstraZeneca to offer drugs to US at discounted prices - Reuters
AstraZeneca (AZN) to Slash Drug Prices in New Deal - GuruFocus
Trump strikes drug-pricing deal with AstraZenecaMSNBC - MarketScreener
AstraZeneca’s stock is climbing after hours following a deal with the Trump White House - MarketWatch
AstraZeneca set to announce drug price deal with Trump administrationBloomberg - Investing.com
AstraZeneca follows Pfizer lead in making drug price deal with Trump - Seeking Alpha
Trump Plans AstraZeneca Deal To Cut Drug Prices For Low-Income AmericansAstraZeneca (NASDAQ:AZN) - Benzinga
AstraZeneca to strike landmark drug price deal with Trump administration - Business Standard
Market Voices: Trump slams China on rare earths, AstraZeneca, UPS - Seeking Alpha
Pattern recognition hints at AstraZeneca PLC Depositary Receipt upside2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com
Will AstraZeneca PLC Depositary Receipt bounce back from current supportGlobal Markets & AI Forecast for Swing Trade Picks - newser.com
AstraZeneca Is Said to Reach Drug-Price Deal With Trump - MSN
AstraZeneca (AZN) Stock Rises Following Positive MSNBC Report - GuruFocus
AstraZeneca Reaches Deal With Trump to Lower Drug Prices - MarketScreener
Trump to announce US drug pricing deal at White House, MSNBC says it's with AstraZeneca - MarketScreener
AstraZeneca Is Said to Reach Landmark Drug Price Deal With Trump - Bloomberg.com
Trump said to unveil AstraZeneca deal today - breakingthenews.net
Trump strikes drug-pricing deal with pharma giant AstraZenecaMSNBC - MarketScreener
UK Weighs 25% Rise In Drug Prices As Pharma Giants Pause Investments - Benzinga
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly - Reuters
AstraZeneca PLC Depositary Receipt stock momentum explained2025 Earnings Impact & Weekly Market Pulse Updates - newser.com
AZN: AstraZeneca Among Companies Watching TrumpRx Developments - GuruFocus
AstraZeneca increases scope of new US API manufacturing facility by $500m - MarketScreener
AstraZeneca Reportedly Nears Drug Pricing Deal With President Trump - Stocktwits
Saudi Arabia Adult Vaccine Market Forecast Report 2025-2033 Featuring Company Analysis and Vaccine Sales of GlaxoSmithKline, AstraZeneca, Sanofi Pasteur, Pfizer, CSL LimitedResearchAndMarkets.com - Business Wire
AstraZeneca sets $4.5bn Virginia API plant construction in motion - Pharmaceutical Technology
Turbine and AstraZeneca partner for ADC discovery - Pharmaceutical Technology
AstraZeneca: $4.5bn investment in Virginia - MarketScreener
Volume spikes in AstraZeneca PLC Depositary Receipt stock – what they meanDollar Strength & High Conviction Investment Ideas - newser.com
AstraZeneca Lifts US Plant Investment to $4.5 Billion to Boost Drug Manufacturing - MarketScreener
AstraZeneca to Invest $4.5 Billion in New US Manufacturing Facility - MarketScreener
아스트라제네카 ADR (AZN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):